참고문헌
- Dahan L, Atlan D, Bouche O, et al (2005). Postoperative chemoradiotherapy after surgical resection of gastric adenocarcinoma: can LV5FU2 reduce the toxic effects of the MacDonald regimen? A report on 23 patients. Gastroenterol Clin Biol, 29, 11-15. https://doi.org/10.1016/S0399-8320(05)80688-8
- Fiorica F, Cartei F, Enea M, et al (2007). The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature data. Cancer Treat Rev, 33, 729-40. https://doi.org/10.1016/j.ctrv.2007.08.005
- Gunderson LL, Sosin H (1974). Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 34, 1278-92. https://doi.org/10.1002/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F
- Hundahl SA, Phillips JL, Menck HR (2000). The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer. 88, 921-32. https://doi.org/10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S
- Jansen EP, Boot H, Saunders MP, et al (2007). A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 69,1424-28. https://doi.org/10.1016/j.ijrobp.2007.05.004
- Kim S, Kim JS, Jeong HY, et al (2011). Retrospective analysis of treatment outcomes after postoperative chemoradiotherapy in advanced gastric cancer. Radiat Oncol J, 29, 252-9. https://doi.org/10.3857/roj.2011.29.4.252
- Kunz PL, Gubens M, Fisher GA, et al (2012). Long-term survivors of gastric cancer: A California population-based study. J Clin Oncol, 30, 3507-15. https://doi.org/10.1200/JCO.2011.35.8028
- Lee HS, Choi Y, Hur WJ, et al (2006). Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine. World J Gastroenterol, 12, 603-7. https://doi.org/10.3748/wjg.v12.i4.603
- Lim DH, Kim DY, Kang MK, et al (2004). Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer, 91, 11-7. https://doi.org/10.1038/sj.bjc.6601896
- Macdonald JS, Smalley SR, Benedetti J, et al (2001). Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med, 345, 725-30. https://doi.org/10.1056/NEJMoa010187
- Marcenaro M, Foppiano F, Durzu S, Barra S, Corvo R (2006). Kidney-sparing radiotherapy by multiple-field threedimensional technique in the postoperative management of the patients with gastric cancer: comparison with standard two-field conformal technique. Tumori, 92, 34-40.
- Milano MT, Garofalo MC, Chmura SJ, et al (2006). Intensitymodulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol, 79, 497-503. https://doi.org/10.1259/bjr/43441736
- Minn AY, Hsu A, La T, et al (2010). Comparison of intensitymodulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer. Cancer, 116, 3943-52. https://doi.org/10.1002/cncr.25246
- Ohri N, Garg MK, Aparo S, et al (2013). Who benefits from adjuvant radiation therapy for gastric cancer? A metaanalysis. Int J Radiat Oncol Biol Phys, 86, 330-5. https://doi.org/10.1016/j.ijrobp.2013.02.008
- Tham CK, Choo SP, Poon DY, et al (2010). Capecitabine with radiation is an effective adjuvant therapy in gastric cancer. World J Gastroenterol, 16, 3709-15. https://doi.org/10.3748/wjg.v16.i29.3709
- Valentini V, Cellini F, Minsky BD, et al (2009). Survival after radiotherapy ingastric cancer: Systematic review and metaanalysis. Radiother Oncol, 92, 176-83. https://doi.org/10.1016/j.radonc.2009.06.014
- Van Cutsem E, Twelves C, Cassidy J, et al (2001). Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol, 19, 4097-106. https://doi.org/10.1200/JCO.2001.19.21.4097
- Wanebo HJ, Kennedy BJ, Chmiel J, et al. (1993). Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 218, 583-92. https://doi.org/10.1097/00000658-199321850-00002
피인용 문헌
- Experimental Study on Sustained-release 5-Fluorouracil Implantation in Canine Peritoneum and Para-aortic Abdominalis vol.15, pp.1, 2014, https://doi.org/10.7314/APJCP.2014.15.1.407
- Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer vol.15, pp.20, 2014, https://doi.org/10.7314/APJCP.2014.15.20.8661
- Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancer vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0737-9
- Capecitabine Pattern of Usage, Rate of Febrile Neutropaenia and Treatment Related Death in Asian Cancer Patients in Clinical Practice vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1449